共 50 条
Comparing the effect of electroacupuncture treatment on obese and non-obese women with stress urinary incontinence or stress-predominant mixed urinary incontinence: A secondary analysis of two randomised controlled trials
被引:1
|作者:
Wang, Weiming
[1
]
Liu, Yan
[2
]
Su, Tongsheng
[3
]
Sun, Yuanjie
[1
]
Liu, Zhishun
[1
]
机构:
[1] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China
[2] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China
[3] Shaanxi Prov Hosp Tradit Chinese Med, Xian, Shaanxi, Peoples R China
关键词:
TRAINING PLUS SOLIFENACIN;
RISK-FACTORS;
EFFICACY;
IMPACT;
PREVALENCE;
DULOXETINE;
OUTCOMES;
PLACEBO;
SAFETY;
D O I:
10.1111/ijcp.13435
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
ObjectiveTo explore whether obesity patients with a body mass index (BMI) of >= 25 kg/m(2) who suffer from stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence (S-MUI) show less improvement in urinary incontinence (UI) symptoms after electroacupuncture (EA) treatment compared with non-obese counterparts. MethodsThis study was a secondary analysis of existing data. About 252 SUI patients and 250 S-MUI patients treated with the same EA regimen were assigned to one of the two groups: the obesity group for BMI >= 25 kg/m(2) and the non-obesity group for BMI <25 kg/ m(2). The primary outcome was the proportion of treatment responders, defined as patients exhibiting a >= 50% reduction in 72-hours incontinence episode frequency, as measured by a 72-hours bladder diary at week 6 compared with baseline. ResultsOf the 1004 randomised women, 129 obese women (86 SUI and 43 S-MUI) and 255 non-obese women (166 SUI and 89 S-MUI) treated with EA were included in a secondary analysis. The primary outcome was that 58.3% (74/127) of patients in the obesity group and 60.7% (150/247) of patients in the non-obesity group (difference 0.55%; 95% confidence interval, -10.01 to 11.11; P = .919) responded to treatment. ConclusionThis study suggests that EA treatment may safely improve UI symptoms in both obese and non-obese patients, regardless of BMI category. Additionally, obesity status may not affect the efficacy of EA treatment on SUI or S-MUI among Chinese women.
引用
收藏
页数:8
相关论文